A significant reduction in the relative reactivity of AGP glycans with LTA was demonstrated in the group of patients with severe COVID-19, both compared to the group of convalescents (p = 0.000018) and the healthy control group (p = 0.000000). This evidence concerns the gene ATP5MK and COVID-19.